Transgenic and knockout mice for DNA repair functions in carcinogenesis and mutagenesis

Toxicology

Volumn 193, Issue 1-2, 2003, Pages 171-187

  Wijnhoven, Susan W P ^a   Van Steeg, Harry ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Carcinogenesis; DNA repair; Mutagenesis; Mutant mouse models; Short term carcinogenicity testing

Indexed keywords

CANCER MODEL; CANCER RISK; CARCINOGEN TESTING; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; EXCISION REPAIR; GENE FREQUENCY; GENE MUTATION; KNOCKOUT MOUSE; MISMATCH REPAIR; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; REVIEW; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS MUSCULUS;

EID: 0242331212     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00295-6     Document Type: Review

References (111)

1. Albertini R.J. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood. Mutat. Res. 150:1985;411-422.
2. Albertini R.J., Castle K.L., Borcherding W.R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. U.S.A. 79:1982;6617-6621.
3. Ames B.N., Gold L.S. Chemical carcinogenesis: too many rodent carcinogens. Proc. Natl. Acad. Sci. U.S.A. 87:1990a;7772-7776.
4. Ames B.N., Gold L.S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 249:1990;970-971.
5. Ames B.N., Lee F.D., Durston W.E. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc. Natl. Acad. Sci. U.S.A. 70:1973;782-786.
6. Baker S.M., Bronner C.E., Zhang L., Plug A.W., Robatzek M., Warren G., Elliott E.A., Yu J., Ashley T., Arnheim N. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
7. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding ligase IV lethality in embryonic mice. Curr. Biol. 8:1998;1395-1398.
8. Berg R.J.W., De Vries A., van Steeg H., De Gruijl F.R. Relative susceptibilities of XPA knockout mice and their heterozygous and wild type littermates to UVB-induced skin cancer. Cancer Res. 57:1997;581-584.
9. Berg R.J.W., Ruven H.J.T., Sands A.T., De Gruijl F.R., Mullenders L.H.F. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J. Invest. Dermatol. 110:1998;405-409.
10. Berg R.J.W., Rebel H., Van der Horst G.T.J., Van Kranen H.J., Mullenders L.H.F., Van Vloten W.A., De Gruijl F.R. Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice. Cancer Res. 60:2000;2858-2863.
11. Bernstein C., Bernstein H., Payne C.M., Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat. Res. 511:2002;145-178.
12. Boerrigter M.E.T.I., Dollé M.E.T., Martus H.-J., Gossen J.A., Vijg J. Plasmid-based transgenic mouse model for studying in vivo mutations. Nature. 377:1995;657-659.
13. Bol S.A.M., van Steeg H., Jansen J.G., van Oostrom C., de Vries A., de Groot A.J.L., Tates A.D., Vrieling H., van Zeeland A.A., Mullenders L.H.F. Elevated frequencies of benzo[a]pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice. Cancer Res. 58:1998;2850-2856.
14. Bootsma, D., Kraemer, K.H., Cleaver, J.E., Hoeijmakers, J.H.J., 1998. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. In: Vogelstein, B., Kinzler, K.W. (Eds.) The Genetic Basis of Human Cancer. McGraw Hill, New York, Chapter 13, pp. 245-274.
15. Breuer M., Siebos R., Verbeek S., Van Lohuizen M., Wientjes E., Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature. 340:1989;61-63.
16. Cheo D.L., Ruven H.J.T., Meira L.B., Hammer R.E., Burns D.K., Tappe N.J., Van Zeeland A.A., Mullenders L.H.F., Friedberg E.C. Characterization of defective nucleotide excision repair in XPC mutant mice. Mutat. Res. Fundam. Mol. Mech. Mutat. 374:1997;1-9.
17. Cheo D.L., Burns D.K., Meira L.B., Houle J.F., Friedberg E.C. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53(-/-) mice. Cancer Res. 59:1999;771-775.
18. Cheo D.L., Meira L.B., Burns D.K., Reis A.M., Issac T., Friedberg E.C. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res. 60:2000;1580-1584.
19. -/- mice. J. Natl. Cancer Inst. 93:2001;1534-1540.
20. Deans B., Griffin C.S., Maconochie M., Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J. 19:2000;6675-6685.
21. De Boer J., de Wit J., van Steeg H., Berg R.J.W., Morreau H., Visser P., Lehmann A.R., Duran M., Hoeijmakers J.H.J., Weeda G. A mouse model for the basal transcription DNA repair syndrome trichothiodystrophy. Mol. Cell. 1:1998;981-990.
22. De Boer J., van Steeg H., Berg R.J.W., Garssen J., de Wit J., van Oostrom C.Th.M., Beems R.B., van der Horst G.T.J., van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H.J., Weeda G. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition. Cancer Res. 59:1999;3489-3494.
23. Dempsey J.L., Odagiri Y., Morley A.A. In vivo mutations at the H-2 locus in mouse lymphocytes. Mutat. Res. 285:1993;45-51.
24. De Vries A., van Steeg H. Xpa knockout mice. Semin. Cancer Biol. 7:1996;229-240.
25. De Vries A., Van Oostrom C.Th.M., Hofhuis F.M., Dortant P.M., Berg R.J.W., De Gruijl F.R., Wester P.W., Van Kreijl C.F., Capel P.J.A., van Steeg H., Verbeek S.J. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature. 377:1995;169-173.
26. De Vries A., Van Oostrom C.Th.M., Dortant P.M., Beems R.B., Van Kreijl C.F., Capel P.J.A., van Steeg H. Spontaneous liver tumours and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol. Carcinogen. 19:1997;46-53.
27. De Wind N., Dekker M., Berns A., Te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and prediposition to cancer. Cell. 82:1995;321-330.
28. Dobrovolsky V.N., Casciano D.A., Heflich R.H. Tk(+/-) mouse model for detecting in vivo mutation in an endogenous, autosomal gene. Mutat. Res. Fundam. Mol. Mech. Mutat. 423:1999;125-136.
29. Dollé M.E.T., Martus H.-J., Gossen J.A., Boerrigter M.E.T.I., Vijg J. Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations. Mutagenesis. 11:1996;111-118.
30. Dollé M.E.T., Giese H., Hopkins C.L., Martus H.J., Hausdorff J.M., Vijg J. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:1997;431-434.
31. Dollé M.E.T., Martus H.-J., Novak M., Van Orsouw N.J., Vijg J. Characterisation of color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection. Mutagenesis. 14:1999;287-293.
32. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
33. Edelmann W., Cohen P.E., Kane M.F., Lau K., Morrow B., Bennett S., Umar A., Kunkel T., Cattoretti G., Chaganti R., Pollard J.W., Kolodner R.D., Kucherlapati R. Meiotic pachatene arrest in MLH1 deficient mice. Cell. 85:1996;1125-1134.
34. Edelmann W., Yang K., Umar A., Kuraguchi M., Heyer J., Lia M., Kneitz B., Fan K., Brown A.M., Lipkin M., Kucherlapati R. Tumorigenesis in Mlh1 and Mlh1/APC1638N mutant mice. Cancer Res. 59:1999;1301-1307.
35. Engle S.J., Stockelman M.G., Chen J., Boivin G., Yum M.N., Davies P.M., Ying M.Y., Sahota A., Simmonds H.A., Stambrook P.J., Tischfield J.A. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5307-5312.
36. Ennever F.K., Noonan T.J., Rosenkranz H.S. The predictivity of animal bioassays and short-term genotoxicity tests for carcinogenicity and non-carcinogenicity to humans. Mutagenesis. 2:1987;73-78.
37. Essers J., Hendriks R.W., Swagemakers S.M., Troelstra C., De Wit J., Bootsma D., Hoeijmakers J.H., Kanaar R. Disruption of mouse RAD54 reduces ionising radiation resistance and homologous recombination. Cell. 89:1997;195-204.
38. Frank K.M., Sekiguchi J.M., Seidl K.J., Swat W., Rathbun G.A., Cheng H.L., Davidson L., Kangaloo L., Alt F.W. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature. 396:1998;173-177.
39. Friedberg E.C., Meira L.B. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage (Version 5). DNA repair. 2:2003;501-530.
40. Friedberg, E.C., Walker, C., Siede, W., 1995. DNA Repair and Mutagenesis. ASM Press, Washington DC.
41. Friedberg E.C., Cheo D.L., Meira L.B., Reis A.M. Cancer development in mutant mice defective in the Xpc DNA repair gene. Prog. Exp. Tumor Res. 35:1999;37-52.
42. Friedberg E.C., Bond J.P., Burns D.K., Cheo D.L., Greenblatt M.S., Meirs L.B., Nahari D., Reis A.M. Defective nucleotide excision repair in Xpc mutant mice and its association with cancer predisposition. Mutat. Res. 459:2000;99-108.
43. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end joining proteins in both lymphogenesis and neurogenesis. Cell. 95:1998;891-902.
44. Garssen J., van Steeg H., De Gruijl F., De Boer J., Van der Horst G.T.J., Van Kranen H., Van Loveren H., Van Dijk M., Fluitman A., Weeda G., Hoeijmakers J.H.J. Transcription-coupled and global genome repair differentially influence UVB-induced acute skin effects and systemic immunosuppression. J. Immunol. 164:2000;6199-6205.
45. Giese H., Dolle M.E.T., Hezel A., van Steeg H., Vijg J. Accelerated accumulation of somatic mutations in mice deficient in the nucleotide excision repair gene XPA. Oncogene. 18:1999;1257-1260.
46. Gorelick N.J. Overview of mutation assays in transgenic mice or routine testing. Environ. Mol. Mutagen. 25:1995;218-230.
47. Gossen J., Vijg J. Transgenic mice as model systems for studying gene mutations in vivo. Trends. Genet. 9:1993;27-31.
48. Gossen J.A., de Leeuw W.J., Tan C.H., Zwarthoff E.C., Berends F., Lohm P.H., Knook D.L., Vijg J. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7971-7975.
49. Gu Y., Seidl K.J., Rathbun G.A., Zhu C., Manis J.P., Van der Stoep N., Davidson L., Cheng H.L., Sekiguchi J.M., Frank K., Stanhope-Baker P., Schlissel M.S., Roth D.B., Alt F.W. Growth retardation and leaky SCID phenotype of Ku70-deficient mice. Immunity. 7:1997;653-665.
50. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;367-374.
51. Ide F., Iida N., Nakatsuru Y., Oda H., Tanaka K., Ishikawa T. Mice deficient in the nucleotide repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors. Carcinogenesis. 21:2000;1263-1265.
52. Ishikawa T., Ide F., Qin X., Zhang S., Takahashi Y., Sekiguchi M., Tanaka K., Nakatsuru Y. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies. Mutat. Res. 477:2001;41-49.
53. Iwakuma T., Sakumi K., Nakatsuru Y., Kawate H., Igarashi H., Shiraishi A., Tsuzuki T., Ishikawa T., Sekiguchi M. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis. 18:1997;1631-1635.
54. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53 mutant mice. Curr. Biol. 4:1994;1-7.
55. Jansen L., Claij N., Dekker M., Van Klink Y., Van der Valk M., Van't Wout K., Te Riele H. Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents. Toxicol. Lett. 112:2000;245-250.
56. Jiricny J. Colon cancer and DNA repair: have mismatches met their match? Trends Genet. 10:1994;164-168.
57. Jones I.M., Burkhart-Schultz K., Carrano A.V. A method to quantify spontaneous and in vivo induced thioguanine-resistant mouse lymphocytes. Mutat. Res. 147:1985;97-105.
58. Karow J.K., Constantinou A., Li J.L., West S.C., Hickson I.D. The Bloom's syndrome gene product promotes branch migration of holliday function. Proc. Natl. Acad. Sci. U.S.A. 97:2000;6504-6508.
59. Kawate H., Itoh R., Sakumi K., Nakabeppu Y., Tsuzuki T., Ide F., Ishikawa T., Noda T., Nawata H., Sekiguchi M. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis. 21:2000;301-305.
60. Klein J.C., Beems R.B., Zwart P.E., Hamzink M., Zomer G., van Steeg H., Van Kreijl C.F. Intestinal toxicity and carcinogenic potential of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4.5-b]pyridine (PhIP) in DNA repair deficient XPA(-/-) mice. Carcinogenesis. 22:2001;619-626.
61. Kohler S.W., Provost G.S., Krets P.L., Dycaico M.J., Sorge J.A., Putman D.L., Short J.M. Development of a short-term in vivo mutagenesis assay: the effects of methylation on the recovery of a lambda shuttle vector from transgenic mice. Nucleic Acids Res. 18:1990;3007-3013.
62. Langland G., Elliot J., Li Y., Creany J., Dixon K., Croden J. The BLM helicase is necessary for normal DNA double strand break repair. Cancer Res. 62:2002;2766-2770.
63. Leder A., Kuo A., Cardiff R.D., Sinn E., Leder P. v-H-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Inst. Sci. U.S.A. 87:1990;9178-9182.
64. Lim D., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal phenotype that is suppressed by a mutation in p53. Mol. Cell Biol. 16:1996;7133-7143.
65. Lindahl T., Wood R.D. Quality control by DNA repair. Science. 286:1999;1897-1905.
66. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;172-215.
67. Mirsalis J.C., Monforte J.A., Winegar R.A. Transgenic animal models for detection of in vivo mutations. Annu. Rev. Pharmacol. Toxicol. 35:1995;255-280.
68. Modrich P., Lahue R. Mismatch repair in replication fidelity. Annu. Rev. Biochem. 65:1996;101-133.
69. Monroe J.J., Kort K.L., Miller J.E., Marino D.R., Skopek T.R. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Bi Blue™ mice. Mutat. Res. Mol. Mech. Mutat. 421:1998;121-136.
70. Murai M., Enokido Y., Inamura N., Yoshino M., Nakatsu Y., Van der Horst G.T.J., Hoeijmakers J.H.J., Tanaka K., Hatanaka H. Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome B DNA repair genes. Proc. Natl. Inst. Sci. U.S.A. 98:2001;13379-13384.
71. Nakane H., Takeuchi S., Yuba S., Saijo M., Nakatsu Y., Murai H., Nakatsuru Y., Ishikawa T., Hirota S., Kitamura Y. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature. 377:1995;165-168.
72. Ng J.Y.N., Vrieling H., Sugosawa K., Ooms M.P., Grootegoed J.A., Vreeburg J.T.M., Visser P., Beems R.B., Gorgels T.G.M.F., Hanaoka F., Hoeijmakers J.H.J., Van der Horst G.T.J. Development defects and male sterility in mice lacking the ubiquitin-like DNA repair gene mHR23B. Mol. Cell Biol. 22:2002;1233-1245.
73. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
74. Ouyang H., Nussenzweig A., Kurimasa A., Soares V.C., Li X., Cordon-Cardo C., Li W., Cheong N., Nussenzweig M., Iliakis G., Chen D.J., Li G.C. Ku70 is required for DNA repair but not for T-cell antigen gene recombination in vivo. J. Exp. Med. 186:1997;921-929.
75. Qin X., Shibata D., Gerson S.L. Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea. Carcinogenesis. 21:2000;833-838.
76. Redhead N.J., Selfridge J., Wu C.L., Melton D.W. Mice with adenine phosphoribosyltransferase deficiency develop fatal 2,8-dihydroxyadenine lithiasis. Hum. Gene Ther. 7:1996;1491-1502.
77. Rijkers T., Van Den Ouweland J., Morolli B., Rolink A.G., Baarends W.M., Van Sloun P.P., Lohman P.H., Pastink A. Targeted inactivation of mouse RAD52 reduces homologous recombination but not resistance to ionising radiation. Mol. Cell. Biol. 18:1998;6423-6429.
78. Rothman G., Shiloh Y. ATM: from gene to function. Hum. Mol. Genet. 7:1998;1555-1563.
79. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katsuki M. Most tumours in transgenic mice with human c-H-ras gene contained somatically activated transgenes. Oncogene. 5:1990;1195-1200.
80. Sakumi K., Shiraishi A., Shimizu S., Tsuzuki T., Ishikawa T., Sekiguchi M. Methylnitrourea-induced tumorigenesis in MGMT gene knockout mice. Cancer Res. 57:1997;2415-2418.
81. Sands A.T., Abuin A., Sanchez A., Conti C.J., Bradley A. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature. 377:1995;162-165.
82. Skopek T.R., Walker V.E., Cochrane J.E., Craft T.R., Cariello N.F. Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7866-7870.
83. Storer R.D., French J.E., Haseman J., Hajian G., LeGrand E.K., Long G.G., Mixson L.A., Ochoa R., Sagartz J.E., Soper K.A. p53(+/-) hemizygous knockout mouse: overview of available data. Toxicol. Pathol. 29(Suppl.):2001;30-50.
84. Sun H., Karow J.K., Hickson I.D., Maizels N. The Bloom's syndrome helicase unwinds G4 DNA. J. Biol. Chem. 273:1998;27587-27592.
85. Takahashi Y., Nakatsuru Y., Zhang S., Shimizu Y., Kume H., Tanaka K., Ide F., Ishikawa T. Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice. Carcinogenesis. 23:2002;627-633.
86. Tanaka K., Satokata I., Ogita Z., Uchida T., Okada Y. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5512-5516.
87. Tates A.D., Van Dam F.J., De Zwart F.A., Van Teijlingen C.M.M., Natarajan A.T. Development of a cloning assay with high cloning efficiency to detect induction of 6-thioguanine-resistant lymphocytes in spleen of adult mice following in vivo inhalation exposure to 1,3-butadiene. Mutat. Res. 309:1994;299-306.
88. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
89. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6236-6240.
90. Van Gent D.C., Hoeijmakers J.H.J., Kanaar R. Chromosomal stability and the DNA double-stranded break connection. Nat. Rev. Genet. 2:2001;196-206.
91. Van der Horst G.T.J., Van Steeg H., Berg R.J.W., Van Gool A.J., De Wit J., Weeda G., Morreau H., Beems R.B., Van Kreijl C.F., De Gruijl F.R., Bootsma D., Hoeijmakers J.H.J. Defective transcription-coupled repair in Cockayne syndrome B deficient mice is associated with skin cancer predisposition. Cell. 89:1997;425-435.
92. Van der Horst G., Meira L., Gorgels T.G.M.F., De Wit J., Velasco-Miguel S., Richardson J.A., Kamp Y., Vreeswijk M.P.G., Smit B., Bootsma D., Hoeijmakers J.H.J., Friedberg E. UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA repair. 1:2002;143-157.
93. Van Kreijl C.F., McAnulty P.A., Beems R.B., Vynckier A., van Steeg H., Fransson-Steen R., Alden C.L., Forster R., Van der Laan J.-W., Vandenberge J. Xpa and Xpa/p53(+/-) knockout mice: overview of available data. Toxicol. Pathol. 29(Suppl.):2001;117-127.
94. Van Oostrom C.Th.M., De Vries A., Verbeek S.J., Van Kreijl C.F., van Steeg H. Cloning and characterisation of the mouse XPAC gene. Nucleic Acids Res. 22:1994;11-14.
95. Van Oostrom C.Th.M., Boeve M., van den Berg J., de Vries A., Dollé M.E.T., Beems R.B., van Kreijl C.F., Vijg J., van Steeg H. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice. Environ. Mol. Mutat. 34:1999;124-130.
96. Van Sloun P.P.H., Wijnhoven S.W.P., Kool H.J.M., Slater R., Weeda G., Van Zeeland A.A., Lohman P.H.M., Vrieling H. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice. Nucleic Acids Res. 26:1998;4888-4894.
97. Van Steeg H., Klein H., Beems R.B., Van Kreijl C.F. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing. Toxicol. Pathol. 26:1998;742-749.
98. Van Steeg H., Mullenders L.H.F., Vijg J. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knockout mice. Mutat. Res. 450:2000;167-180.
99. Vijg J., van Steeg H. Transgenic assays for mutations and cancer: current status and future perspectives. Mutat. Res. 400:1998;337-354.
100. Vogel H., Lim D.S., Karsenty G., Finegold M., Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl. Acad. Sci. U.S.A. 96:1999;10770-10775.
101. Vrieling H., Wijnhoven S.W.P., Van Sloun P.P.H., Kool H.J., Giphart-Gassler M., Van Zeeland A.A. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo. Environ. Mol. Mutagen. 34:1999;84-89.
102. Wijnhoven S.W.P., Van Sloun P.P.H., Kool H.J., Weeda G., Slater R., Lohman P.H.M., Van Zeeland A.A., Vrieling H. Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse. Proc. Natl. Acad. Sci. 95:1998;13759-13764.
103. Wijnhoven S.W.P., Kool H.J., Mullenders L.H.F., Van Zeeland A.A., Friedberg E.C., Van der Horst G.T.J., van Steeg H., Vrieling H. Age-dependent spontaneous mutagenesis in Xpc mice defective in nucleotide excision repair. Oncogene. 19:2000a;5034-5037.
104. Wijnhoven S.W.P., Kool H.J., Van Oostrom C.T.M., Beems R.B., Mullenders L.H.F., Van Zeeland A.A., Van der Horst G.T.J., Vrieling H., van Steeg H. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice. Cancer Res. 60:2000b;5681-5687.
105. Wijnhoven S.W.P., Kool H.J., Van Teijlingen C.M.M., Van Zeeland A.A., Vrieling H. Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation? Mutat. Res. 473:2001;23-36.
106. Wijnhoven S.W.P., Sonneveld E., Kool H.J., Van Teijlingen C.M.M., Vrieling H. Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis. 24:2003;139-144.
107. Wilson S.H. Mammalian base excision repair and DNA polymerase beta. Mutat. Res. 407:1998;203-215.
108. Winton D.J., Blount M.A., Ponder P.A. A clonal marker induced by mutation in mouse intestinal epithelium. Nature. 333:1988;463-466.
109. Yoshino M., Nakatsu Y., Te Riele H., Hirota S., Kitamura Y., Tanaka K. Additive roles of XPA and MSH2 genes in UVB-induced skin tumorigenesis in mice. DNA Repair. 1:2002;935-940.
110. Zeiger E. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenisis assay for rodent carcinogenicity. Cancer Res. 47:1987;1287-1296.
111. Zhu C., Bogue M.A., Lim D.S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodifiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.